ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire.
ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire. Now known as ArisGlobal agBalance, the solution allows safety experts to directly engage in signal detection and drive the results through signals management into risk management. Regulators and the industry can access the integrated platform for detecting safety issues and communicating the changing benefit-risk profile of medicinal products to the health community in a timely manner. Read the full release here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Datopotamab Deruxtecan Achieves Superior Survival Compared to Chemo in Advanced Nonsquamous NSCLC
May 30th 2024Patients with locally advanced or metastatic non-small cell lung cancer who were previously administered at least one line of therapy showed superior overall survival compared to docetaxel.